COVID CASE DISCUSSION - 45 year female
This is an online e log book to discuss our patient de-identified health data shared after taking his / her / guardians signed informed consent. Here we discuss our individual patients problems through series of inputs from available global online community of experts with an aim to solve those patients clinical problem with collective current best evident based input.
This E blog also reflects my patient centered online learning portfolio and your valuable inputs on the comment box is welcome.A 45 year old female presented with complaints of fever, shortness of breathe, loose stools.
K.Lasya Mithra, 8th semester
Roll No: 50
I have been given this case to solve in an attempt to understand the
topic of " patient clinical data analysis" to develop my
competency in reading and comprehending clinical data including history,
clinical findings, investigations and come up with diagnosis and treatment
plan.
CASE:
A 45 yr old female who is cook in a school presented to hospital with chief complaints of
- Fever - 1 week
- Shortness of breathe - 4 days
- loose stools - from morning
HISTORY OF PRESENT ILLNESS:
Patient was apparently asymptomatic 1 week back then she developed
- Fever which is sudden in onset, high grade, with no associated chills and rigors. She was tested COVID positive and also gives a contact history with her husband who was COVID positive.
- She developed of shortness of breathe from 4 days which was insidious in onset initially grade-2 ( on exertion) and gradually progressed to grade-4 (on rest). It was not associated with chest pain, palpitations, sweating.
- Patient complained of loose stools since morning and had 2 episodes.
second episode- dark, tar coloured, watery consistency
- complaint of burning micturition from 5- 6 yrs which is intermittent and was on medication.
- No history of vomiting.
- Known case of hypothyroidism from 10 years and on medication Thyronorm- 150 mcg, OD.
- No history of diabetes, hypertension, asthma, epilepsy, TB, CVD.
- Appetite: Normal
- Diet: Mixed
- Bowel and Bladder: Burning micturition - from 5-6 yrs, which is intermittent and relived temporarily on medication. Patient also complained of constipation.
- Sleep: adequate
- Addictions: absent
- no history of drug and food allergies.
FAMILY HISTORY:
- Husband was tested COVID-19 positive
- No history of diabetes, hypertension, thyroid, CVD in family.
GENERAL EXAMINATION:
- Patient is conscious, coherent and cooperative
- moderately built and nourished
- pallor: absent
- Icterus: absent
- Cyanosis: absent
- Clubbing: absent
- Edema: absent
- Lymphadenopathy: absent
- Vitals: ( on presentation)
- pulse rate: 120 bpm
- Blood pressure: 100/60 mm Hg
- Temperature: febrile
- respiratory rate: 35 cycles/min
- spO2: 78% at RA
INVESTIGATIONS:
CBP:
- Hemoglobin : 7.4 gm/dl
- TLC : 9,900 cells/cumm
- Platelets : 2.43 lakh
- PCV : 24.5
CRP : Positive, 2.4 mg/dl
ESR : 80
D- DIMER : 1520 ng/ml
LDH : 481 IU/L
ABG :
- pH : 7.14
- pCO2 : 37.2
- pO2 : 59.9
- HCO3 : 23.2
- St.HCO3 : 23.7
- BEB : - 0.6
- BEecf :- 0.7
- TCO2 : 49.7
- O2 sat : 80.7
- O2 count : 9.1
RFT:
HRCT :
- CORADS - 5
- CT Severity - 23/25
DIAGNOSIS:
Viral pneumonia secondary COVID - 19 and known case of hypothyroidism.
TREATMENT:
02-05-21 ( On day of admission - day 4 of symptoms)
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg
- BP, PR, spO2 - monitor hrly
- Foleys catheterization
- I/O Charting ( urine output)
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 150 mcg, PO, OD
03-05-21 (day 5 of symptoms)
Vitals :
- Temperature: afebrile
- Pulse rate: 80 bpm
- BP : 110/70 mm Hg
- spO2 : 96% on 10 lit of O2
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 150 mcg, PO, OD
- Inj. CLEXANE - 0.4 cc, OD
04-05-21( day 6 of symptoms)
Investigations:
- CBP :
- Hemoglobin : 7.6 gm/dl
- TLC : 12,900 cells/ cumm
- Platelets : 2.76 lakh
- Reticulocyte count : 0.6
- ESR : 85
Vitals:
- Temperature: 98.6 F
- Pulse rate: 78 bpm
- BP : 100/60 mm Hg
- spO2 : 94% on 14 lit of O2
- respiratory rate: 50 cpm
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 150 mcg, PO, OD
- Inj. CLEXANE - 0.4 cc, OD
- Inj. TRANEXA- 500 mg, slow IV stat
05-05-21( day 7 of symptoms)
Vitals:
- Temperature: 98.6 F
- Pulse rate: 96 bpm
- BP : 120/70 mm Hg
- spO2 : 95%
- respiratory rate: 25 cpm
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg, PO
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 125 mcg, PO, OD
06-05-21( day 8 of symptoms)
Vitals:
- Temperature: 98.6 F
- Pulse rate: 90 bpm
- BP : 100/70 mm Hg
- spO2 : 94%
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg , PO
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 125 mcg, PO, OD
- Inj. TRANEXA- 500 mg, slow IV stat
07-05-21( day 9 of symptoms)
Vitals:
- Temperature: 98.6 F
- Pulse rate: 106 bpm
- BP : 90/70 mm Hg
- spO2 : 98% on 10 lit of O2
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, PO, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 125 mcg, PO, OD
- IV Fluids- NS- 75 ml/hr
08-05-21( day 10 of symptoms)
chest x- ray was taken
Vitals:
- Temperature: 98.6 F
- Pulse rate: 112 bpm
- BP : 100/60 mm Hg
- spO2 : 98% on 10 lit of O2
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT - 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 125 mcg, PO, OD
- IV Fluids - NS- 75ml/hr
09-05-21(day 11 of symptoms)
worsening of symptoms.
Vitals:
- Temperature: 98.6 F
- Pulse rate: 128 bpm
- BP : 100/60 mm Hg
- spO2 : 74% on 15 lit of O2, on venturi mask
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT and DUOLIN- 8th hourly
- Syp. ASCORYL - 10ml, TID
- Tab. PCM - 650 mg
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 125 mcg, PO, OD
- Inj. CLEXANE - 40 mg, BD
- IV Fluids - NS - 75ml/hr
10-05-21( day 12 of symptoms)
8 :00 am
Vitals:
- Temperature: 98.6 F
- Pulse rate: 120 bpm
- BP : 100/60 mm Hg
- spO2 : < 80% on 16 lit of O2 , started CPAP with 100% FiO2
Treatment:
- O2 inhalation to maintain spO2 > 90%
- Nebulisation with BUDECORT and DUOLIN - 8th hourly
- Syp. ASCORYL - 10ml, PO, TID
- Tab. PCM - 650 mg, PO
- BP, PR, spO2 - monitor hrly
- I/O Charting
- Tab. PANTOP- 40 mg, OD
- Inj. DEXAMETHASONE - 8mg, IV, OD
- Tab. THYRONORM - 125 mcg, PO, OD
- Inj. CLEXANE - 40 mg, OD
- IV Fluids- NS- 75ml/hr
12:30 pm
- Pulse rate: 136 bpm
- respiratory rate: 56 cpm
- BP: 110/70mm Hg
- spO2: 87% with CPAP and 16 lit of O2
4:40 pm
- Pulse rate: 120 bpm
- respiratory rate: 50 cpm
- BP: 110/70mm Hg
- spO2: 95% with CPAP and 16 lit of O2
Due to worsening of symptoms ECG was taken
There occurred gradually deterioration of symptoms on midnight of this day( 10-05-21) i.e patient was struggling to breathe inspite of all efforts (saturation started dropping even on 100% FiO2 ) . Patient became unresponsive and expired on 11-05-21 at 6:25 AM.
I would like to thank Dr. Rakesh Biswas sir ( H.O.D, General Medicine) for giving me this opportunity and thank you Dr. Vamshi Sir (P.G, General Medicine) for the guidance.
Comments
Post a Comment